In an unexpected turnaround, on December 26 2000, the Clinton administration killed a proposal to allow imports of low-priced prescription drugs into the United States. Congress abandoned the controversial plan on the grounds that it would be unsafe and would not achieve its aim of providing the public with cheap drugs. Describing the proposal as severely flawed, Donna E Shalala , secretary of health and human services, echoed the concerns of pharma companies who believed that without sufficient funding and strict regulations, the plan would have had a devastating effect on public safety.